A Novel Engineered Composite Construct for Articular Cartilage Repair

Information

  • Research Project
  • 7051890
  • ApplicationId
    7051890
  • Core Project Number
    R43EB006538
  • Full Project Number
    1R43EB006538-01
  • Serial Number
    6538
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/22/2006 - 18 years ago
  • Project End Date
    1/31/2007 - 17 years ago
  • Program Officer Name
    KELLEY, CHRISTINE A.
  • Budget Start Date
    6/22/2006 - 18 years ago
  • Budget End Date
    1/31/2007 - 17 years ago
  • Fiscal Year
    2006
  • Support Year
    1
  • Suffix
  • Award Notice Date
    6/22/2006 - 18 years ago
Organizations

A Novel Engineered Composite Construct for Articular Cartilage Repair

[unreadable] DESCRIPTION (provided by applicant): There is a major clinical need for products to repair articular cartilage defects. The objective of this project is to develop a chondral repair device for articular cartilage that can be formed in vivo, and adheres to the surrounding host articular cartilage. The project uses two recently developed and complementary technologies that together have the potential to provide a mechanically functional and stable implant for articular cartilage repair. The intent of this Phase I project is to determine the feasibility of this product concept. The hypothesis for this proposal is that a composite construct with mechanical properties similar to native articular cartilage can be formed, adhered to native cartilage and provide an in situ articular chondral repair. To test the hypothesis three Specific Aims are proposed. Specific Aim 1. Optimize the composite construct to compressive and tensile properties of native human adult articular cartilage. Component variables will be assessed in a factorial study, to determine the optimal combination of biomaterials that provide tensile and compressive properties similar to native articular cartilage. Specific Aim 2. Optimize adherence of the composite construct to articular cartilage. Specific Aim 3. Demonstrate formation and attachment of the device in situ. The conditions identified in Aims 1 and 2 will be used to determine if the composite construct can be assembled within an articular defect in situ. The successful completion of this Phase I project will lead to a Phase II project, where the objective will be to determine safety and effectiveness of the device and method in vivo, using appropriate animal models. If successful, the data generated from these studies will be used in an IDE submission to the FDA to initiate a clinical trial. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING
  • Activity
    R43
  • Administering IC
    EB
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    222759
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    375
  • Ed Inst. Type
  • Funding ICs
    NCMHD:222758\NIBIB:1\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SYNTHASOME, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SAN DIEGO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    92109
  • Organization District
    UNITED STATES